Epogen reduces the need for blood transfusions among dialysis patients, and counters the fatigue from long sessions. It's been in production since 1989.
But according to this news report (22 July, 2011), new guidelines have questioned the safety of this and related drugs. According to the report at Vcstar.com, "the FDA finally announced on June 24 new guidelines that are projected to slash the
Subscribe to:
Post Comments (Atom)
Post a Comment